Policy & Regulations

This channel includes news coverage of healthcare policy and regulations set by Congress, the states, Centers for Disease Control and Prevention (CDC), the Department of Health and Human Services (HHS), U.S. Food and Drug Administration (FDA), and medical associations and societies. 

Thumbnail

FDA announces recall of Cardiohelp ECMO emergency drives due to serious risks

If the emergency drive is needed during treatment, it could fail to work, putting patients at risk of ischemia, hypoxia, stroke or death.

artificial intelligence regulation legislation

House lawmakers advance bill to blunt radiologist pay cut in 2024

Several MD members of Congress are co-sponsoring the “Physician Fee Schedule Update and Improvements Act." 

New York Albany capitol

ACR, state radiological society urge governor to veto bill related to wrongful death damages

“Any action that would increase medical liability costs carries the potential negative consequence of physicians leaving our state to practice elsewhere," the two said. 

nurse burnout stock image

Washington nurses demand action over patient violence

Some 44 nurses from Seattle Children’s Hospital have signed onto a letter attributing the chaos to a “systemic crisis in pediatric mental health.”

Cigna

Radiology groups express ‘profound objection’ to Cigna policy change

“It is our firm belief that such a classification does a disservice to patients," the American Society of Neuroradiology, Society for Interventional Radiology and others wrote recently. 

venture capital corporate suit business corporatization

Loss of autonomy a top concern among physicians working for private equity or other corporate owners

Another two-thirds of physicians reported having little or no involvement in practice management policies, according to a survey conducted by NORC at the University of Chicago.  

Kit Crancer RBMA president on Medicare cuts RSNA 2023.

The impact of Medicare payment cuts on radiology and patient care access

RBMA President Kit Crancer said continued cuts will result in Medicare patients losing access to care when health systems and providers determine it is no longer economical.

phenylephrine FDA

Congressional group wants to grill FDA on recently rejected OTC decongestant

Three months after an FDA panel declared a popular cold remedy no more effective than a sugar pill, a House oversight panel wants to ask FDA leadership a pointed question: What took you so long?